Indian Journal of Experimental Biology 1991-07-01

Efficacy of methyl 5(6)-(alpha-hydroxyphenylmethyl) benzimidazole-2-carbamate, a metabolite of mebendazole, against developing forms of experimental helminth parasites.

S Gupta, J K Srivastava, M K Jain, J C Katiyar, J Singh, D S Bhakuni

Index: Indian J. Exp. Biol. 29(7) , 645-8, (1991)

Full Text: HTML

Abstract

Methyl 5(6)-(alpha-hydroxyphenylmethyl) benzimidazole-2- carbamate, a metabolite of mebendazole, was evaluated against metamorphic forms of Ancylostoma ceylanicum in hamsters, Nippostrongylus brasiliensis in rats and cysticercoids of Hymenolepis nana in grain beetles. The test compound offered better action than mebendazole except against H. nana cysticercoids where the activity of the compound and mebendazole was comparable, but was inferior to the standard cestodicidal drug, praziquantel. The results suggest that the action was better by ip route compared to per os route of drug administration.


Related Compounds

Related Articles:

Development and validation of an ultra high performance liquid chromatography tandem mass spectrometry method for simultaneous determination of sulfonamides, quinolones and benzimidazoles in bovine milk.

2014-07-01

[J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 962 , 20-9, (2014)]

Alterations in metabolic activity of Cysticercus fasciolaris on some anthelmintic treatments.

1992-04-01

[Indian J. Exp. Biol. 30(4) , 320-3, (1992)]

Residue study of mebendazole and its metabolites hydroxy-mebendazole and amino-mebendazole in eel (Anguilla anguilla) after bath treatment.

1997-03-01

[Drug Metab. Dispos. 25(3) , 317-20, (1997)]

Development and validation of a liquid chromatography-electrospray tandem mass spectrometry method for mebendazole and its metabolites hydroxymebendazole and aminomebendazole in sheep liver.

2001-12-01

[Analyst 126(12) , 2144-8, (2001)]

Liquid chromatography with electrochemical detection for monitoring mebendazole and hydroxymebendazole in echinococcosis patients.

1984-01-01

[Ther. Drug Monit. 6(2) , 215-20, (1984)]

More Articles...